HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Victor L Serebruany Selected Research

Ticagrelor

12/2015Ticagrelor shift from PLATO to PEGASUS: Vanished mortality benefit, excess cancer deaths, massive discontinuations, and overshooting target events.
11/2015Solid cancers after antiplatelet therapy: Confirmations, controversies, and challenges.
9/2015Survival After Solid Cancers in Antithrombotic Trials.
9/2015Among antithrombotic agents, prasugrel, but not ticagrelor, is associated with reduced 30 day mortality in patients with ST-elevated myocardial infarction.
3/2015Excessive long-term platelet inhibition with prasugrel or ticagrelor and risk of infection: another hidden danger?
1/2014Dyspnea and reversibility of antiplatelet agents: ticagrelor, elinogrel, cangrelor, and beyond.
8/2013Letter by Serebruany and DiNicolantonio regarding article, "Ticagrelor in patients with acute coronary syndromes and stroke: interpretation of subgroups in clinical trials".
7/2013Viewpoint: mismatch between the European and American guidelines on oral antiplatelet P2Y12 inhibitors after acute coronary syndromes.
5/2013Exploring the reduction in myocardial infarctions in the PLATO trial: which patients benefited on ticagrelor vs. clopidogrel?
1/2013Impact of clopidogrel and potent P2Y 12 -inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Victor L Serebruany Research Topics

Disease

27Myocardial Infarction
01/2016 - 08/2002
26Hemorrhage
12/2015 - 04/2003
24Stroke (Strokes)
12/2015 - 03/2003
17Acute Coronary Syndrome
12/2015 - 12/2002
16Heart Failure
01/2015 - 01/2002
9Neoplasms (Cancer)
12/2015 - 05/2009
8Thrombosis (Thrombus)
05/2015 - 02/2003
8Coronary Artery Disease (Coronary Atherosclerosis)
01/2015 - 02/2003
8Vascular Diseases (Vascular Disease)
07/2010 - 01/2004
4Cardiovascular Diseases (Cardiovascular Disease)
03/2014 - 05/2004
4Unstable Angina
05/2013 - 12/2002
3Peripheral Arterial Disease
01/2016 - 01/2009
3Headache (Headaches)
11/2014 - 05/2006
3Dyspnea (Shortness of Breath)
01/2014 - 11/2012
3Atrial Fibrillation
05/2011 - 01/2010
2Sepsis (Septicemia)
12/2015 - 11/2014
2Hypertension (High Blood Pressure)
11/2014 - 01/2006
2Atherosclerosis
01/2013 - 07/2007
2Nausea
01/2013 - 02/2008
2Inflammation
01/2013 - 01/2012
2Vomiting
01/2013 - 02/2008
2Constipation
01/2013 - 11/2010
2Sudden Death
01/2011 - 01/2010
2Type 2 Diabetes Mellitus (MODY)
02/2008 - 01/2008
2Transient Ischemic Attack
02/2008 - 01/2007
2Myocardial Ischemia (Ischemic Heart Diseases)
03/2003 - 08/2002
1Body Weight (Weight, Body)
01/2016
1Coronary Disease (Coronary Heart Disease)
12/2015
1Arteriosclerosis
12/2015
1Infection
03/2015
1Mitral Valve Insufficiency (Mitral Regurgitation)
01/2015
1Contusions
11/2014
1Pneumonia (Pneumonitis)
11/2014
1Exanthema (Rash)
11/2014
1Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
11/2014
1Lung Neoplasms (Lung Cancer)
01/2013
1Diarrhea
01/2013
1Kidney Diseases (Kidney Disease)
01/2013
1Neoplasm Metastasis (Metastasis)
01/2013
1Venous Thromboembolism
01/2013
1Dyspepsia (Indigestion)
01/2013
1Acute Lung Injury
12/2012
1Angioedema
11/2012
1Renal Insufficiency (Renal Failure)
11/2012
1Gliosis
01/2012
1Genetic Predisposition to Disease (Genetic Predisposition)
05/2011
1Chronic Kidney Failure (Chronic Renal Failure)
03/2011

Drug/Important Bio-Agent (IBA)

37Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
12/2015 - 06/2002
34clopidogrel (Plavix)FDA Link
12/2015 - 02/2003
23prasugrelIBA
11/2015 - 01/2008
16TicagrelorIBA
12/2015 - 01/2010
10Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2016 - 01/2004
8Biological Markers (Surrogate Marker)IBA
01/2015 - 01/2002
7Dipyridamole (Persantine)FDA LinkGeneric
02/2008 - 04/2003
42'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
12/2015 - 01/2013
3Thrombin Receptors (Thrombin Receptor)IBA
12/2015 - 01/2012
3Fibrinolytic Agents (Antithrombotic Agents)IBA
11/2015 - 11/2013
3PyrimidinesIBA
09/2015 - 01/2010
3valsartan (Vals)FDA Link
11/2014 - 05/2004
3cangrelorIBA
01/2014 - 11/2013
3Warfarin (Coumadin)FDA LinkGeneric
01/2013 - 03/2003
3AdenosineFDA LinkGeneric
12/2012 - 01/2010
3dipyridamole drug combination aspirinFDA LinkGeneric
05/2006 - 04/2003
3Serotonin Uptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
04/2006 - 09/2005
2ThrombinFDA Link
01/2016 - 09/2015
2ThienopyridinesIBA
09/2015 - 12/2012
2elinogrelIBA
01/2014 - 12/2012
2eptifibatide (Integrilin)FDA Link
01/2014 - 12/2002
2rosuvastatin (Crestor)FDA Link
01/2013 - 06/2008
2Brain Natriuretic Peptide (Natrecor)FDA Link
03/2011 - 01/2002
2C-Reactive ProteinIBA
03/2011 - 03/2004
2CD31 AntigensIBA
07/2010 - 09/2003
2P-SelectinIBA
07/2010 - 09/2003
2Purinergic P2 Receptors (ADP Receptor)IBA
10/2003 - 03/2003
1phorbol 12-pyrenebutyrate 13-(3,3,3-trifloro-2-diazopropioate)IBA
12/2015
1SCH 530348IBA
12/2015
1apixabanIBA
09/2015
1OsteopontinIBA
01/2015
1aliskirenFDA Link
11/2014
1tirofiban (Aggrastat)FDA Link
01/2014
1Glycoproteins (Glycoprotein)IBA
01/2014
1abciximab (ReoPro)FDA Link
01/2014
1atorvastatin (Lipitor)FDA Link
01/2013
1ezetimibe (Zetia)FDA Link
01/2013
1Simvastatin (Zocor)FDA LinkGeneric
01/2013
1Ticlopidine (Ticlid)FDA LinkGeneric
12/2012
1AntithrombinsIBA
12/2012
1AngiotensinsIBA
11/2012
1Angiotensin Receptor AntagonistsIBA
11/2012
1L-SelectinIBA
01/2012
12',3'-Cyclic-Nucleotide Phosphodiesterases (2',3' Cyclic Nucleotide Phosphodiesterase)IBA
01/2012
1Nerve Growth Factor (NGF)IBA
01/2012
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2012
1erucylphosphocholineIBA
01/2012
1von Willebrand FactorIBA
06/2011
1Troponin T (T, Troponin)IBA
03/2011
1EstersIBA
01/2011
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2011

Therapy/Procedure

8Stents
05/2015 - 10/2002
1Off-Label Use
11/2014